Investor Relations
2023-2024
HONASA CONSUMER LIMITED
HONASA CONSUMER LIMITED
To be updated post quarter results.
To be updated in the respective quarter.
To be updated in the respective quarter.
Intimation of Investor Call
Earnings Presentation Q3 FY24
Outcome of Board Meeting Results Q3
Press Release Results Q3
Audio Recording – Analyst / Investor Conference Call Q3 & 9MFY24
Transcript – Analyst Investor Conference Call Q3FY24
To be updated post quarter results.
Code for Independent Directors
Code of Conduct Board and Senior Management Team
CSR Policy
Dividend Distribution Policy
Familiarization Programme
Nomination & Remuneration Policy
Policy for determining materiality of events information
Policy on Board Evaluation and Performance
Policy on Succession planning for Board and SM
Preservation of Documents Policy
Risk Management Policy
Whistle Blower Policy
Policy on materiality of related party transactions and on dealing with related party transactions
Material Contracts
MC_2 Registrar Agreement Executed
MC_4 Share Escrow Agreement Executed
MC_5 Syndicate Agreement Executed
MC_6 Agreement Underwriting Agreement Executed
Material Documents
MD_1 and 2 Latest Copy of MOA and AOA amended from time to time
MD_3 CTC of Resolution of Board approving the offer
MD_4 BR and IPO Resoltuion DRHP Approval_Final
MD_5 CTC of Board and IPO Committee
MD_6 Consent of the Selling Shareholders
MD_8 SHA Amendment Agreement Executed 15.12.2022
MD_9 SHA Amendment Agreement Executed 13.10.2023
MD_10 Employment Agreement_ Execution version- Varun Alagh
MD_11 Employment Agreement_ Execution version- Ghazal Alagh
MD_12_Consent letter of Auditors
MD_13 Examination Report _RFS_V3
MD_14 Statement of Direct Tax Benefits
MD_16 Consent from BB Associates
MD_17 Resolution approving KPI
MD_18 & 30 Industry report by Redseer
MD_19 Consent letter by GoldVIP
MD_20 Consent letter by NielsenIQ
MD_21 Certificate by BB Associates
MD_22 SPSSA- 22 dec 2021-Just4kids
MD_23 MOU-Honasa Consumer and Momspresso -20102022
MD_24 Momspresso SHA addendum_24 june 2022
MD_24 SHA 22dec2021-Momspresso
MD_25 Execution Version_SSSPA_170222
MD_26 Aneesh_HCPL – Share Purchase Agreement (20112022)
MD_27 & 28 SHA addendum 11th Aug 2022- Fusion Cosmeceutics Pvt Ltd
MD_27 Shareholders Agreement_17 February 2022_Sheths
MD_31 Special purpose FS FY 20& FY 21
MD_32 Complaint Email of JK from SEBI
MD_33 Annual report FY 21 Part-1
MD_33 Annual Report FY 21 Part 2
MD_33 Annual Report FY 21 Part 3
MD_33 Annual Report FY 21 Part 4
MD_33 Annual Report FY 22 Part 5
MD_33 Annual Report FY 23 Part 6
MD_35 In-principle Listing approvals by BSE NSE
MD_36 Triparte Agreement with NSDL
MD_37 Triparte Agreement with CDSL
MD_38 SEBI Final Observation Letter
Red Herring Prospectus
Prospectus Honasa Consumer Limited
Disclaimer – Important
THESE MATERIALS ARE NOT DIRECTED AT OR INTENDED TO BE ACCESSED BY PERSONS LOCATED OUTSIDE INDIA.
IMPORTANT: You must read and agree with the terms and conditions of the following disclaimer before continuing.
The following disclaimer applies to the Red Herring Prospectus of Honasa Consumer Limited (the “Company”) dated October 23, 2023 (the “Red Herring Prospectus”) filed with the Registrar of Companies, National Capital Territory of Delhi and Haryana at New Delhi and thereafter with the Securities and Exchange Board of India (“SEBI”) and the BSE Limited and the National Stock Exchange of India Limited, in relation to the initial public offering of the equity shares of face value of ₹ 10 each (“Equity Shares”) of the Company (“Offer”).
THE RED HERRING PROSPECTUS IS BEING MADE AVAILABLE ON THIS WEBSITE TO COMPLY WITH SECURITIES AND EXCHANGE BOARD OF INDIA (ISSUE OF CAPITAL AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2018, AS AMENDED (“SEBI ICDR REGULATIONS”). You are advised to read this disclaimer carefully before reading, accessing or making any other use of the Red Herring Prospectus. In accessing the Red Herring Prospectus, you agree to be bound by the following terms and conditions, including any modifications to them from time to time.
The Red Herring Prospectus is directed at, and is intended for distribution to, and use by, residents of India only. The information in this portion of our website, including the Red Herring Prospectus, is not for publication or distribution, directly or indirectly, in or into the United States. No part of the contents of the Red Herring Prospectus shall be copied or duplicated in any form by any means, or redistributed. The information contained in the Red Herring Prospectus may not be updated since its original publication date and may not reflect the latest updates.
The Red Herring Prospectus has been hosted on this website as prescribed under Regulation 26 of the SEBI ICDR Regulations. You are reminded that documents transmitted in electronic form may be altered or changed during the process of transmission and consequently, neither the Company nor any of its affiliates accepts any liability or responsibility whatsoever in respect of alterations or changes which have taken place during the course of transmission of electronic data.
The Red Herring Prospectus does not constitute an offer to sell or an invitation to subscribe to the securities offered in any jurisdiction to any person to whom it is unlawful to make an offer or invitation in such jurisdiction and is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where (a) distribution or use of such information would be contrary to law or regulation; or (b) the Company or any of its affiliates would by virtue of such distribution become subject to new or additional registration, licensing or other regulatory requirements. The Equity Shares offered in the Offer have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws in the United States, and unless so registered may not be offered or sold within the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable state securities laws. Accordingly, such Equity Shares are being offered and sold (i) outside of the United States in “offshore transactions” as defined in and in compliance with Regulation S under the U.S. Securities Act and the applicable laws of the jurisdiction where those offers and sales occur; and (ii) to “qualified institutional buyers” (as defined in Rule 144A under the U.S. Securities Act) pursuant to Section 4(a) of the U.S. Securities Act. No person outside India is eligible to bid for Equity Shares in the Offer unless that person has received the preliminary offering memorandum for the Offer, which comprises the Red Herring Prospectus and the preliminary international wrap (which contains, among other things, the selling restrictions for the Offer outside India).
Any person into whose possession the Red Herring Prospectus comes is required to inform himself or herself about and to observe any such restrictions.
Neither the Company nor any of its affiliates will be responsible for any loss or damage that could result from interception and interpretation by any third parties of any information being made available to you through this website. The Company and its affiliates cannot and do not guarantee the accuracy, timeliness or completeness of the information being made available to you in the Red Herring Prospectus beyond the date of the Red Herring Prospectus. The information in the Red Herring Prospectus is as of the date thereof and neither the Company nor its affiliates, directors or employees are under any obligation to update or revise the Red Herring Prospectus to reflect circumstances arising after the date thereof.
Any potential investor should note that investment in equity shares involves a high degree of risk and for details relating to such risks, see the section titled “Risk Factors” in the Red Herring Prospectus. Any decision on whether to invest in the equity shares described in the red herring prospectus of the Company dated October 23, 2023 (“RHP”), must be made solely on the basis of the RHP. As there may be material changes in the draft red herring prospectus dated December 28, 2022 (the “DRHP”) versus the RHP, potential investors should not have relied on the DRHP.
The Company and its affiliates will not be responsible for any loss to any person or entity caused by any shortcoming, defect or inaccuracy which may have inadvertently or otherwise crept into the website. Neither the Company, any of its affiliates nor their directors, officers and employees will be liable or have any responsibility of any kind for any loss or damage that you incur in the event of any failure or disruption of this website, or resulting from the act or omission of any other party involved in making this website or the data contained therein available to you, or from any other cause relating to your access to, inability to access, or use of the website or these materials.
If you are not permitted to view the materials on this website or are in any doubt as to whether you are permitted to view these materials, please exit this webpage.
To access this information, you must confirm by pressing on the button marked “I Confirm” that, at the time of access you are located in India. If you cannot make this confirmation, you must press the button marked “I Do Not Confirm”.
The documentation contained in these pages is posted solely to comply with Indian legal and regulatory requirements. Making the information contained herein available in electronic format does not constitute an offer to sell, the solicitation of an offer to buy, or a recommendation to buy or sell securities of the Company in the United States or in any other jurisdiction, including without limitation, India.
FY20
Signed Audit Report and FS Mar20
FY21
Honasa Financials FY 21 Final
FY22
Honasa Standalone FY 22
Code for Independent Directors
Code of Conduct Board and Senior Management Team
CSR Policy
Dividend Distribution Policy
Familiarization Programme
Nomination & Remuneration Policy
Policy for determining materiality of events information
Policy on Board Evaluation and Performance
Policy on Succession planning for Board and SM
Preservation of Documents Policy
Risk Management Policy
Whistle Blower Policy
Policy on materiality of related party transactions and on dealing with related party transactions
Press Release_11.03.2024
Press Release_05.03.2024
Press Release_28.02.2024
Statement of Deviation
Postal Ballot_Voting Result & Scrutinizer Report
Newspaper Publication_Postal Ballot
Intimation of Postal Ballot Notice
Window Closure Notice Dec 2023
Investors_Call_Intimation
Board_Meeting_Notice
Newspaper Publication
MC_2 Registrar Agreement Executed
MC_4 Share Escrow Agreement Executed
MC_5 Syndicate Agreement Executed
MC_6 Agreement Underwriting Agreement Executed
MD_1 and 2 Latest Copy of MOA and AOA amended from time to time
MD_3 CTC of Resolution of Board approving the offer
MD_4 BR and IPO Resoltuion DRHP Approval_Final
MD_5 CTC of Board and IPO Committee
MD_6 Consent of the Selling Shareholders
MD_8 SHA Amendment Agreement Executed 15.12.2022
MD_9 SHA Amendment Agreement Executed 13.10.2023
MD_10 Employment Agreement_ Execution version- Varun Alagh
MD_11 Employment Agreement_ Execution version- Ghazal Alagh
MD_12_Consent letter of Auditors
MD_13 Examination Report _RFS_V3
MD_14 Statement of Direct Tax Benefits
MD_16 Consent from BB Associates
MD_17 Resolution approving KPI
MD_18 & 30 Industry report by Redseer
MD_19 Consent letter by GoldVIP
MD_20 Consent letter by NielsenIQ
MD_21 Certificate by BB Associates
MD_22 SPSSA- 22 dec 2021-Just4kids
MD_23 MOU-Honasa Consumer and Momspresso -20102022
MD_24 Momspresso SHA addendum_24 june 2022
MD_24 SHA 22dec2021-Momspresso
MD_25 Execution Version_SSSPA_170222
MD_26 Aneesh_HCPL – Share Purchase Agreement (20112022)
MD_27 & 28 SHA addendum 11th Aug 2022- Fusion Cosmeceutics Pvt Ltd
MD_27 Shareholders Agreement_17 February 2022_Sheths
MD_31 Special purpose FS FY 20& FY 21
MD_32 Complaint Email of JK from SEBI
MD_33 Annual report FY 21 Part-1
MD_33 Annual Report FY 21 Part 2
MD_33 Annual Report FY 21 Part 3
MD_33 Annual Report FY 21 Part 4
MD_33 Annual Report FY 22 Part 5
MD_33 Annual Report FY 23 Part 6
MD_35 In-principle Listing approvals by BSE NSE
MD_36 Triparte Agreement with NSDL
MD_37 Triparte Agreement with CDSL
MD_38 SEBI Final Observation Letter
Prospectus Honasa Consumer Limited
NewspaperPublication
NewspaperPublication – Corrigendum of postal ballot notice
Statement of Deviation
Postal Ballot_Voting Result & Scrutinizer Report
Newspaper Publication_Postal Ballot
Intimation of Postal Ballot Notice
Window Closure Notice Dec 2023
Investors_Call_Intimation
Appointment Letter Format
Board_Meeting_Notice
Newspaper Publication
Disclaimer
THESE MATERIALS ARE NOT DIRECTED AT OR INTENDED TO BE ACCESSED BY PERSONS LOCATED OUTSIDE INDIA.
IMPORTANT: You must read and agree with the terms and conditions of the following disclaimer before continuing.
The following disclaimer applies to the Red Herring Prospectus of Honasa Consumer Limited (the “Company”) dated October 23, 2023 (the “Red Herring Prospectus”) filed with the Registrar of Companies, National Capital Territory of Delhi and Haryana at New Delhi and thereafter with the Securities and Exchange Board of India (“SEBI”) and the BSE Limited and the National Stock Exchange of India Limited, in relation to the initial public offering of the equity shares of face value of ₹ 10 each (“Equity Shares”) of the Company (“Offer”).
THE RED HERRING PROSPECTUS IS BEING MADE AVAILABLE ON THIS WEBSITE TO COMPLY WITH SECURITIES AND EXCHANGE BOARD OF INDIA (ISSUE OF CAPITAL AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2018, AS AMENDED (“SEBI ICDR REGULATIONS”). You are advised to read this disclaimer carefully before reading, accessing or making any other use of the Red Herring Prospectus. In accessing the Red Herring Prospectus, you agree to be bound by the following terms and conditions, including any modifications to them from time to time.
The Red Herring Prospectus is directed at, and is intended for distribution to, and use by, residents of India only. The information in this portion of our website, including the Red Herring Prospectus, is not for publication or distribution, directly or indirectly, in or into the United States. No part of the contents of the Red Herring Prospectus shall be copied or duplicated in any form by any means, or redistributed. The information contained in the Red Herring Prospectus may not be updated since its original publication date and may not reflect the latest updates.
The Red Herring Prospectus has been hosted on this website as prescribed under Regulation 26 of the SEBI ICDR Regulations. You are reminded that documents transmitted in electronic form may be altered or changed during the process of transmission and consequently, neither the Company nor any of its affiliates accepts any liability or responsibility whatsoever in respect of alterations or changes which have taken place during the course of transmission of electronic data.
The Red Herring Prospectus does not constitute an offer to sell or an invitation to subscribe to the securities offered in any jurisdiction to any person to whom it is unlawful to make an offer or invitation in such jurisdiction and is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where (a) distribution or use of such information would be contrary to law or regulation; or (b) the Company or any of its affiliates would by virtue of such distribution become subject to new or additional registration, licensing or other regulatory requirements. The Equity Shares offered in the Offer have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws in the United States, and unless so registered may not be offered or sold within the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable state securities laws. Accordingly, such Equity Shares are being offered and sold (i) outside of the United States in “offshore transactions” as defined in and in compliance with Regulation S under the U.S. Securities Act and the applicable laws of the jurisdiction where those offers and sales occur; and (ii) to “qualified institutional buyers” (as defined in Rule 144A under the U.S. Securities Act) pursuant to Section 4(a) of the U.S. Securities Act. No person outside India is eligible to bid for Equity Shares in the Offer unless that person has received the preliminary offering memorandum for the Offer, which comprises the Red Herring Prospectus and the preliminary international wrap (which contains, among other things, the selling restrictions for the Offer outside India).
Any person into whose possession the Red Herring Prospectus comes is required to inform himself or herself about and to observe any such restrictions.
Neither the Company nor any of its affiliates will be responsible for any loss or damage that could result from interception and interpretation by any third parties of any information being made available to you through this website. The Company and its affiliates cannot and do not guarantee the accuracy, timeliness or completeness of the information being made available to you in the Red Herring Prospectus beyond the date of the Red Herring Prospectus. The information in the Red Herring Prospectus is as of the date thereof and neither the Company nor its affiliates, directors or employees are under any obligation to update or revise the Red Herring Prospectus to reflect circumstances arising after the date thereof.
Any potential investor should note that investment in equity shares involves a high degree of risk and for details relating to such risks, see the section titled “Risk Factors” in the Red Herring Prospectus. Any decision on whether to invest in the equity shares described in the red herring prospectus of the Company dated October 23, 2023 (“RHP”), must be made solely on the basis of the RHP. As there may be material changes in the draft red herring prospectus dated December 28, 2022 (the “DRHP”) versus the RHP, potential investors should not have relied on the DRHP.
The Company and its affiliates will not be responsible for any loss to any person or entity caused by any shortcoming, defect or inaccuracy which may have inadvertently or otherwise crept into the website. Neither the Company, any of its affiliates nor their directors, officers and employees will be liable or have any responsibility of any kind for any loss or damage that you incur in the event of any failure or disruption of this website, or resulting from the act or omission of any other party involved in making this website or the data contained therein available to you, or from any other cause relating to your access to, inability to access, or use of the website or these materials.
If you are not permitted to view the materials on this website or are in any doubt as to whether you are permitted to view these materials, please exit this webpage.
To access this information, you must confirm by pressing on the button marked “I Confirm” that, at the time of access you are located in India. If you cannot make this confirmation, you must press the button marked “I Do Not Confirm”.
The documentation contained in these pages is posted solely to comply with Indian legal and regulatory requirements. Making the information contained herein available in electronic format does not constitute an offer to sell, the solicitation of an offer to buy, or a recommendation to buy or sell securities of the Company in the United States or in any other jurisdiction, including without limitation, India.
Investors Contact
Mr. Dhanraj Dagar
Company Secretary and Compliance Officer
Tel: 011 – 44123544
Email: [email protected]
Corporate Office:
Honasa Consumer Limited
10th Floor, Capiral Cyberscape, Ullahwas, Sector-59, Gurugram, Haryana – 122102
Registered Office:
Honasa Consumer Limited
Unit No – 404, 4th Floor, City Centre, Plot No 05, Sector-12, Dwarka, New Delhi – 110075